Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Lipogen, Inc. — Predicate Candidate Screening
15 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
50 daysmedian FDA review time
149 days90th percentile
15clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K902636 | LIPOGEN RHEUMELISA DSDNA ASSAY | Lipogen, Inc. | 1990-06-28 | 14 | 0 |
| K895996 | RHEUMELISA ASSAY FOR SM AUTOANTIBODIES | Lipogen, Inc. | 1989-11-06 | 24 | 0 |
| K895997 | RHEUMELISA ASSAY FOR RNP AUTOANTIBODIES | Lipogen, Inc. | 1989-11-06 | 24 | 0 |
| K895995 | RHEUMELISA ASSAY FOR SS-B/LA AUTOANTIBODIES | Lipogen, Inc. | 1989-10-27 | 14 | 0 |
| K895994 | RHEUMELISA ASSAY FOR SS-A/RO AUTOANTIBODIES | Lipogen, Inc. | 1989-10-24 | 11 | 0 |
| K894659 | ANA ANTISERA CONTROL KIT | Lipogen, Inc. | 1989-09-21 | 59 | 0 |
| K892421 | MODIFIED ACCESS R-CLONE ANA/RF SCREENING TEST | Lipogen, Inc. | 1989-05-09 | 29 | 0 |
| K885048 | ACCESS R-CLONE ANA PROFILE ASSAY | Lipogen, Inc. | 1989-01-24 | 48 | 0 |
| K882740 | ACCESS R-CLONE(TM) ANA/RF SCREENING ASSAY | Lipogen, Inc. | 1988-09-22 | 83 | 0 |
| K880254 | SM ANTIBODY TEST KIT | Lipogen, Inc. | 1988-04-06 | 77 | 0 |
| K874195 | LA ANTIBODY TEST KIT | Lipogen, Inc. | 1988-03-11 | 149 | 0 |
| K874152 | RNP ANTIBODY TEST KIT | Lipogen, Inc. | 1988-03-11 | 150 | 0 |
| K875246 | LIPOGEN ANA TEST KIT | Lipogen, Inc. | 1988-02-10 | 50 | 0 |
| K874151 | RF DIPSTICK TEST KIT | Lipogen, Inc. | 1987-12-29 | 77 | 0 |
| K874191 | NDNA ANTIBODY TEST KIT | Lipogen, Inc. | 1987-12-18 | 65 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda